Jump to content

Medicare Prescription Drug Price Negotiation Act

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Forbes72 (talk | contribs) at 04:59, 15 September 2020 (removed Category:110th United States Congress; added Category:Proposed legislation of the 110th United States Congress using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

In January 2007, the 110th United States House of Representatives approved H.R. 4, the Medicare Prescription Drug Price Negotiation Act,[1] a bill to require federal officials to negotiate with drug companies for lower prices for the 23 million senior citizens who have signed up for Medicare's prescription drug coverage. If passed, the law would repeal a ban on letting the government negotiate with manufacturers for lower prices — a provision that was part of the GOP-sponsored 2003 measure called the Medicare Prescription Drug, Improvement, and Modernization Act, which created the prescription drug program.[2]

References

  1. ^ Prescription Drug Price Comparison by www.ePharmacies.com
  2. ^ House OKs bill on cost of drugs, LA Times, 1/13/07.